TY - JOUR
T1 - Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease
T2 - Results of the CARP trial
AU - McFalls, Edward O.
AU - Ward, Herbert B.
AU - Moritz, Thomas E.
AU - Apple, Fred S.
AU - Goldman, Steve
AU - Pierpont, Gordon
AU - Larsen, Greg C.
AU - Hattler, Brack
AU - Shunk, Kendrick
AU - Littooy, Fred
AU - Santilli, Steve
AU - Rapp, Joseph
AU - Thottapurathu, Lizy
AU - Krupski, William
AU - Reda, Domenic J.
AU - Henderson, William G.
N1 - Funding Information:
Supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development.
PY - 2008/2
Y1 - 2008/2
N2 - Aims: The predictors and outcomes of patients with a peri-operative elevation in cardiac troponin I above the 99th percentile of normal following an elective vascular operation have not been studied in a homogeneous cohort with documented coronary artery disease. Methods and results: The Coronary Artery Revascularization Prophylaxis (CARP) trial was a randomized trial that tested the benefit of coronary artery revascularization prior to vascular surgery. Among 377 randomized patients, core lab samples for peak cardiac troponin I concentrations were monitored following the vascular operation and the blinded results were correlated with outcomes. A peri-operative myocardial infarction (MI), defined by an increase in cardiac troponin I greater than the 99th percentile reference (≥0.1 μg/L), occurred in 100 patients (26.5%) and the incidence was not dissimilar in patients with and without pre-operative coronary revascularization (24.2 vs. 28.6%; P = 0.32). By logistic regression analysis, predictors of MI (odds risk; 95%CI; P-value) were age >70 (1.84; 1.14-2.98; P = 0.01), abdominal aortic surgery (1.82; 1.09-3.03; P = 0.02), diabetes (1.86; 1.11-3.11; P = 0.02), angina (1.67; 1.03-2.64; P = 0.04), and baseline STT abnormalities (1.62; 1.00-2.6; P = 0.05). At 2.5 years post-surgery, the probability of survival in patients with and without the MI was 0.73 and 0.84, respectively (P = 0.03, log-rank test). Using a Cox proportional hazards regression analysis, a peri-operative MI in diabetic patients was a strong predictor of long-term mortality (hazards ratio: 2.43; 95% CI: 1.31-4.48; P < 0.01). Conclusion: Among patients with coronary artery disease who undergo vascular surgery, a peri-operative elevation in cardiac troponin levels is common and in combination with diabetes, is a strong predictor of long-term mortality. These data support the utility of cardiac troponins as a means of stratifying high-risk patients following vascular operations.
AB - Aims: The predictors and outcomes of patients with a peri-operative elevation in cardiac troponin I above the 99th percentile of normal following an elective vascular operation have not been studied in a homogeneous cohort with documented coronary artery disease. Methods and results: The Coronary Artery Revascularization Prophylaxis (CARP) trial was a randomized trial that tested the benefit of coronary artery revascularization prior to vascular surgery. Among 377 randomized patients, core lab samples for peak cardiac troponin I concentrations were monitored following the vascular operation and the blinded results were correlated with outcomes. A peri-operative myocardial infarction (MI), defined by an increase in cardiac troponin I greater than the 99th percentile reference (≥0.1 μg/L), occurred in 100 patients (26.5%) and the incidence was not dissimilar in patients with and without pre-operative coronary revascularization (24.2 vs. 28.6%; P = 0.32). By logistic regression analysis, predictors of MI (odds risk; 95%CI; P-value) were age >70 (1.84; 1.14-2.98; P = 0.01), abdominal aortic surgery (1.82; 1.09-3.03; P = 0.02), diabetes (1.86; 1.11-3.11; P = 0.02), angina (1.67; 1.03-2.64; P = 0.04), and baseline STT abnormalities (1.62; 1.00-2.6; P = 0.05). At 2.5 years post-surgery, the probability of survival in patients with and without the MI was 0.73 and 0.84, respectively (P = 0.03, log-rank test). Using a Cox proportional hazards regression analysis, a peri-operative MI in diabetic patients was a strong predictor of long-term mortality (hazards ratio: 2.43; 95% CI: 1.31-4.48; P < 0.01). Conclusion: Among patients with coronary artery disease who undergo vascular surgery, a peri-operative elevation in cardiac troponin levels is common and in combination with diabetes, is a strong predictor of long-term mortality. These data support the utility of cardiac troponins as a means of stratifying high-risk patients following vascular operations.
KW - Cardiac risks
KW - Coronary artery revascularization
KW - Myocardial infarction
KW - Outcomes
KW - Troponins
KW - Vascular surgery
UR - http://www.scopus.com/inward/record.url?scp=38849150989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38849150989&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehm620
DO - 10.1093/eurheartj/ehm620
M3 - Article
C2 - 18245121
AN - SCOPUS:38849150989
SN - 0195-668X
VL - 29
SP - 394
EP - 401
JO - European heart journal
JF - European heart journal
IS - 3
ER -
